Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer.

ESMO Open · 2021 · PMC8417333 · PMID 34481329

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of marginal significanceno p-value reported

Again, strong associations were observed in case of treatment with PD-L1 monotherapy only, while for chemo-immunotherapy, associations were absent or of marginal significance, with the only exception being the association between LDH and OS ( Supplementary Table S3 , available at https://doi.org/10.1016/j.esmoop.2021.100254 ).

also in 464 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.